
Masimo - Home
Mar 23, 2011 · Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide …
Masimo - Wikipedia
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive …
Masimo - Home
Learn how to use the Masimo SafetyNet monitoring system, including setting up the mobile app and applying a sensor, with simple instructions and videos
What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive
Sep 30, 2024 · What’s next at Masimo after CEO Kiani’s exit? Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation …
Danaher Deal Finalized: Company To Acquire Masimo For $9.9
Feb 17, 2026 · The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization.
Masimo Shareholders Approve Acquisition by Danaher
May 4, 2026 · Masimo (Nasdaq: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative …
FinancialContent - Danaher's $9.9 Billion Bet: Masimo Acquisition to ...
Feb 17, 2026 · Summary and Market Outlook The Danaher-Masimo deal is a landmark $9.9 billion transaction that marks the end of an era for Masimo as an independent entity and the beginning of a …
Danaher to acquire pulse oximeter maker Masimo in $9.9 billion deal ...
Feb 17, 2026 · In a blockbuster deal announced on February 17, 2026, industrial conglomerate Danaher Corp has agreed to acquire medical technology firm Masimo Corp for $9.9 billion, including debt.
Masimo Set to Join Beckman Owner, Danaher, in $9.9 Billion Deal
Feb 23, 2026 · Irvine medical device maker Masimo has entered an agreement to be acquired by Danaher, owner of Brea-based Beckman Coulter, in a $9.9 billion deal.
Masimo - About
For over 35 years, Masimo has developed innovative monitoring technologies designed to improve patient outcomes and streamline clinical workflows. From the NICU to the operating room to the …